Welcome to our dedicated page for MYOMO SEC filings (Ticker: MYO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MYOMO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MYOMO's regulatory disclosures and financial reporting.
MYOMO, INC. director F. Kirk reported an open-market purchase of 25,000 shares of Common Stock on May 28, 2026 at $0.993 per share. The shares were bought in multiple lots at this price. Following the transaction, his direct holdings increased to 653,863 shares.
MYOMO, INC. Chief Medical Officer Harry Kovelman reported open-market sales of company common stock over two days. He sold 20,464 shares on May 27, 2026 at a weighted average price of $1.002 per share and 11,536 shares on May 28, 2026 at a weighted average price of $1.0172 per share. After these transactions, he continued to hold 108,618 shares directly.
Rule 144 notice filed to sell Common stock. The filing lists 11,536 shares of Common stock as securities to be sold on 06/28/2025 classified as Restricted Stock and names Morgan Stanley Smith Barney LLC as the broker. The filing also records a past sale of 20,464 shares by Harry Kovelman on 05/27/2026.
MYO filed a Form 144 notice reporting proposed sales of restricted common stock by an affiliate. The filing lists planned sales on multiple dates with per‑date share quantities, including 06/28/2024 384 shares; 06/29/2024 254 shares; 06/03/2025 7,311 shares; and others. Shares outstanding were 05/27/2026 38,638,653.
MYOMO, INC. director F. Thomas Kirk reported two open-market purchases of common stock. On May 15, 2026, he bought 31,605 shares at a weighted average price of $0.9096 per share, in multiple lots priced between $0.815 and $0.91.
On May 18, 2026, he bought an additional 43,401 shares at a weighted average price of $0.91 per share, with individual trades between $0.9041 and $0.91. After these purchases, he directly owns 628,863 common shares.
Myomo, Inc. received an amended Schedule 13D from Horton Capital entities and Joseph M. Manko Jr., disclosing beneficial ownership of 2,309,775 common shares, or about 6.0% of the company based on 38,638,653 shares outstanding as of May 1, 2026.
The shares, held through Horton Capital Partners Fund, were bought in open-market transactions for an aggregate purchase price of about $3.6 million. Manko was appointed to Myomo’s board of directors effective May 9, 2026, to serve until the 2027 annual meeting.
Horton Capital submitted a shareholder proposal for the 2026 proxy asking Myomo to declassify its board so all directors stand for annual election. The filing notes the group may continue to engage with management and other shareholders and could increase or decrease its stake over time.
MYOMO, INC. director Joseph M. Manko Jr., through Horton Capital Partners Fund, LP, reported net open-market purchases of 201,197 MYO shares. The fund bought 170,830 shares at an average price of $0.8602 per share on May 14, 2026, and 30,367 shares at $0.8878 per share on May 15, 2026. Following these indirect transactions, the fund’s reported MYO holdings rose to 2,309,775 shares.
MYOMO, INC. director Joseph M. Manko Jr. filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows indirect ownership of 2,108,578 MYO shares, held through Horton Capital Partners Fund, LP, reflecting his existing stake rather than a new transaction.
MYOMO, INC. Chief Commercial Officer Micah Mitchell reported an open-market sale of 90,231 shares of common stock on May 14. The weighted average sale price was $0.861 per share, with individual trades executed between $0.85 and $0.889 per share. After these transactions, Mitchell directly owns 109,478 shares of Myomo common stock.
MYO filed a Form 144 reporting a proposed sale of 90,231 shares of Common Stock by Morgan Stanley Smith Barney LLC Executive Financial Services. The submission lists multiple tranches of restricted stock dated 06/05/2024, 06/07/2024, 06/28/2024, 03/11/2025, 06/05/2025, and 06/28/2025.
The form provides per‑tranche counts (for example, 24,500 shares on 06/28/2024 and 40,000 shares on 06/28/2025) and names the selling broker. Timing and sale mechanics beyond the listed dates are not detailed in the excerpt.